Cargando…

Elucidating the Anti-Tumorigenic Efficacy of Oltipraz, a Dithiolethione, in Glioblastoma

Glioblastoma multiforme (GBM), the most aggressive primary brain tumor, displays a highly infiltrative growth pattern and remains refractory to chemotherapy. Phytochemicals carrying specificity and low cytotoxicity may serve as potent and safer alternatives to conventional chemotherapy for treating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapoor-Narula, Upasana, Lenka, Nibedita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562012/ https://www.ncbi.nlm.nih.gov/pubmed/36231019 http://dx.doi.org/10.3390/cells11193057

Ejemplares similares

Chemical genomics of cancer chemopreventive dithiolethiones
por: Tran, Quynh T., et al.
Publicado: (2009)

Analgesic and Antidepressant Effects of Oltipraz on Neuropathic Pain in Mice by Modulating Microglial Activation
por: Díaz, Andrés Felipe, et al.
Publicado: (2019)

Further structure–activity relationships study of substituted dithiolethiones as glutathione-inducing neuroprotective agents
por: Brown, Dennis A., et al.
Publicado: (2016)

Anethole Dithiolethione Increases Glutathione in Kidney by Inhibiting γ-Glutamyltranspeptidase: Biochemical Interpretation and Pharmacological Consequences
por: Giustarini, Daniela, et al.
Publicado: (2020)

Oltipraz ameliorates the progression of steatohepatitis in Nrf2-null mice fed a high-fat diet
por: Kamisako, Toshinori, et al.
Publicado: (2022)

Dithiolethione Compounds Inhibit Akt Signaling in Human Breast and Lung Cancer Cells by Increasing PP2A Activity
por: Switzer, Christopher H., et al.
Publicado: (2009)

Slow-Release H(2)S Donor Anethole Dithiolethione Protects Liver From Lipotoxicity by Improving Fatty Acid Metabolism
por: Zhao, Chengcheng, et al.
Publicado: (2020)

NUCLEAR DEFECTIVE IL-33 DRIVES AN ANTI-TUMORIGENIC MICROENVIRONMENT IN GLIOBLASTOMA
por: Menon, Shyam V, et al.
Publicado: (2023)

Snail depletes the tumorigenic potential of glioblastoma
por: Savary, K, et al.
Publicado: (2013)

Oltipraz Prevents High Glucose-Induced Oxidative Stress and Apoptosis in RSC96 Cells through the Nrf2/NQO1 Signalling Pathway
por: Jiang, Zengxin, et al.
Publicado: (2020)

Beneficial effects of Oltipraz, nuclear factor - erythroid – 2 - related factor 2 (Nrf2), on renal damage in unilateral ureteral obstruction rat model
por: Polat, Emre Can, et al.
Publicado: (2018)

Effects of C2-Ceramide and Oltipraz on Hepatocyte Nuclear Factor-1 and Glutathione S-Transferase A1 in Acetaminophen-Mediated Acute Mice Liver Injury
por: Ma, Xin, et al.
Publicado: (2018)

Sprouty2 enhances the tumorigenic potential of glioblastoma cells
por: Park, Jong-Whi, et al.
Publicado: (2018)

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme
por: Becker, Yvonne, et al.
Publicado: (2019)

Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche
por: Caylioglu, Deniz, et al.
Publicado: (2021)

Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo
por: Parhi, Priyambada, et al.
Publicado: (2017)

Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
por: Zhang, Fengyu, et al.
Publicado: (2020)

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
por: Lamballe, Fabienne, et al.
Publicado: (2016)

Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
por: Tenan, Mirna, et al.
Publicado: (2000)

REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
por: Conti, Luciano, et al.
Publicado: (2012)

Role of Lamin A/C as Candidate Biomarker of Aggressiveness and Tumorigenicity in Glioblastoma Multiforme
por: Gatti, Giuliana, et al.
Publicado: (2021)

Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma
por: Tunici, Patrizia, et al.
Publicado: (2004)

DGKζ Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma
por: Gu, Xuefeng, et al.
Publicado: (2019)

Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
por: Fujikawa, Akihiro, et al.
Publicado: (2017)

GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
por: Watson, Dionysios C., et al.
Publicado: (2023)

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
por: Golebiewska, Anna, et al.
Publicado: (2013)

Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma
por: Mikheev, Andrei M., et al.
Publicado: (2018)

Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli
por: Sahu, Upasana, et al.
Publicado: (2017)

Correction: REST Controls Self-Renewal and Tumorigenic Competence of Human Glioblastoma Cells
Publicado: (2015)

Phospholipase D1 inhibition sensitizes glioblastoma to temozolomide and suppresses its tumorigenicity
por: Kang, Dong Woo, et al.
Publicado: (2020)

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma
por: Ma, Qing, et al.
Publicado: (2017)

Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
por: Donoghue, Jacqueline F., et al.
Publicado: (2018)

Elucidating the pathogenic and biomarker potentials of FOXG1 in glioblastoma
por: Richard, Seidu A., et al.
Publicado: (2020)

A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR
por: Al-Mayhani, Talal F, et al.
Publicado: (2019)

Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity
por: Sun, Peng, et al.
Publicado: (2014)

RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma
por: Zhou, Jiesi, et al.
Publicado: (2023)

MGCG regulates glioblastoma tumorigenicity via hnRNPK/ATG2A and promotes autophagy
por: Chu, Fang, et al.
Publicado: (2023)

Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles
por: Wijewantha, Nisitha, et al.
Publicado: (2023)

Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
por: Mughal, Awais A., et al.
Publicado: (2015)

Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potential
por: Smith, Stuart James, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_47bu66plffu1fv52o4euhd5g17